US Bancorp DE decreased its holdings in Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) by 12.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 54,857 shares of the company’s stock after selling 7,598 shares during the period. US Bancorp DE’s holdings in Ryan Specialty were worth $4,052,000 at the end of the most recent reporting period.
Several other large investors have also recently modified their holdings of RYAN. Whittier Trust Co. of Nevada Inc. increased its stake in shares of Ryan Specialty by 281.6% in the first quarter. Whittier Trust Co. of Nevada Inc. now owns 332 shares of the company’s stock worth $25,000 after purchasing an additional 245 shares in the last quarter. Golden State Wealth Management LLC purchased a new position in Ryan Specialty during the first quarter valued at approximately $35,000. Kapitalo Investimentos Ltda purchased a new position in Ryan Specialty during the fourth quarter valued at approximately $36,000. Fifth Third Bancorp grew its stake in Ryan Specialty by 202.5% during the first quarter. Fifth Third Bancorp now owns 484 shares of the company’s stock valued at $36,000 after acquiring an additional 324 shares in the last quarter. Finally, Headlands Technologies LLC grew its stake in Ryan Specialty by 2,644.8% during the fourth quarter. Headlands Technologies LLC now owns 796 shares of the company’s stock valued at $51,000 after acquiring an additional 767 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.
Insiders Place Their Bets
In related news, EVP Mark Stephen Katz sold 14,377 shares of the company’s stock in a transaction on Friday, June 13th. The shares were sold at an average price of $65.84, for a total transaction of $946,581.68. Following the completion of the sale, the executive vice president directly owned 1,117 shares in the company, valued at $73,543.28. This represents a 92.79% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director David P. Bolger sold 5,000 shares of the company’s stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total transaction of $354,000.00. Following the sale, the director owned 71,467 shares of the company’s stock, valued at $5,059,863.60. This represents a 6.54% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 52.21% of the company’s stock.
Ryan Specialty Trading Up 0.1%
Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The company reported $0.66 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.66. The firm had revenue of $855.17 million during the quarter, compared to analyst estimates of $837.52 million. Ryan Specialty had a net margin of 6.81% and a return on equity of 48.70%. The business’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.58 EPS. As a group, equities research analysts forecast that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current year.
Ryan Specialty Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, August 26th. Investors of record on Tuesday, August 12th will be issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, August 12th. Ryan Specialty’s dividend payout ratio is currently 137.14%.
Wall Street Analysts Forecast Growth
Several equities analysts recently commented on the stock. UBS Group reduced their price objective on shares of Ryan Specialty from $84.00 to $80.00 and set a “buy” rating for the company in a research note on Monday. TD Cowen assumed coverage on shares of Ryan Specialty in a research note on Thursday, April 10th. They set a “buy” rating and a $89.00 price objective for the company. Keefe, Bruyette & Woods reduced their price objective on shares of Ryan Specialty from $76.00 to $75.00 and set an “outperform” rating for the company in a research note on Wednesday, April 9th. Barclays reduced their price objective on shares of Ryan Specialty from $83.00 to $79.00 and set an “overweight” rating for the company in a research note on Monday, July 7th. Finally, Wall Street Zen raised shares of Ryan Specialty from a “sell” rating to a “hold” rating in a research note on Sunday. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Ryan Specialty has an average rating of “Moderate Buy” and a consensus price target of $77.30.
View Our Latest Stock Analysis on RYAN
About Ryan Specialty
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Recommended Stories
- Five stocks we like better than Ryan Specialty
- Why is the Ex-Dividend Date Significant to Investors?
- Unusual Machines: A Speculation With Tailwinds to Lift Its Price
- Insider Trading – What You Need to Know
- Zebra Technologies: Riding the Automation Wave to Profits
- How Investors Can Find the Best Cheap Dividend Stocks
- Vertical Aerospace’s New Deal and Earnings De-Risk Production
Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report).
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.